ESSILOR (EPA:EL) ESSILOR - Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2010
Transparency directive : regulatory news
23/08/2010 18:00
Click here to download pdf version
Regulatory Information
Disclosure of Share Capital and Voting Rights
Outstanding as of July 31, 2010
(Pursuant to Article L.233-8 II of the French Commercial Code and articles
221-1 and 223-16 of the General Regulations of the Autorité des Marchés
Financiers)
Charenton-le-Pont, France (August 23, 2010 - 06:00 pm) - As of July 31,
shares and voting rights outstanding of Essilor, the world leader in ophthalmic
optics, broke down as follows:
July 31, 2010
Shares outstanding 212,993,957
Exercisable voting rights 228,308,379
Total potential voting rights, including rights 231,141,425
attached to shares held in treasury and under the
liquidity contract.
The world leader in ophthalmic optical products, Essilor
International researches, develops, manufactures and markets around the world a
wide range of lenses to correct myopia, hyperopia, presbyopia and astigmatism.
Its flagship brands are Varilux(r), Crizal(r), Essilor(r), Definity(r) and
Xperio(TM).
Based in France, the company reported consolidated revenue of EUR3.2
billion in 2009, with 34,700 employees and operations in 100 countries.
For more information, please visit www.essilor.com.
The Essilor share trades on the NYSE Euronext Paris market and is included in
the CAC 40 index. Codes and symbols:
ISIN: FR FR0000121667; Reuters: ESSI.PA; Bloomberg: EI:FP.
Investor Relations and Financial Communications
www.essilor.com
Phone: +33 (0)1 49 77 42 16